Literature DB >> 1689051

Beta-adrenergic stimulation of calcium channels occurs by potentiation of high-activity gating modes.

D T Yue1, S Herzig, E Marban.   

Abstract

cAMP-dependent phosphorylation clearly increases current through cardiac L-type Ca channels, but the molecular manifestation of this effect remains controversial. Previous work implicates either an increase in the number of functional channels or graded changes in the gating of individual channels. We now find that single cardiac Ca channels display three patterns of activity ("modes") and that isoproterenol or 8-bromoadenosine 3',5'-cyclic monophosphate redistributes the relative proportions of modes such that the two most active (mode 1, bursts of brief openings; mode 2, very long-lasting openings) are favored (P less than 0.05; n = 7). Conversely, a pattern of sparse brief openings (mode 0a) is selectively inhibited (P less than 0.01). Despite differences in the relative frequencies of the various modes before and during drug exposure, the gating within each mode is not detectably changed. We conclude that potentiation of highly active modes of Ca channel gating underlies the enhancement of calcium influx by beta-adrenergic stimulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689051      PMCID: PMC53344          DOI: 10.1073/pnas.87.2.753

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Beta-adrenergic modulation of the slow gating process of cardiac calcium channels.

Authors:  R Ochi; N Hino; H Okuyama
Journal:  Jpn Heart J       Date:  1986-11

2.  Fast and slow gating behaviour of single calcium channels in cardiac cells. Relation to activation and inactivation of calcium-channel current.

Authors:  A Cavalié; D Pelzer; W Trautwein
Journal:  Pflugers Arch       Date:  1986-03       Impact factor: 3.657

3.  Correcting single channel data for missed events.

Authors:  A L Blatz; K L Magleby
Journal:  Biophys J       Date:  1986-05       Impact factor: 4.033

4.  Rapid beta-adrenergic modulation of cardiac calcium channel currents by a fast G protein pathway.

Authors:  A Yatani; A M Brown
Journal:  Science       Date:  1989-07-07       Impact factor: 47.728

5.  A G protein directly regulates mammalian cardiac calcium channels.

Authors:  A Yatani; J Codina; Y Imoto; J P Reeves; L Birnbaumer; A M Brown
Journal:  Science       Date:  1987-11-27       Impact factor: 47.728

6.  Dihydropyridine inhibition of neuronal calcium current and substance P release.

Authors:  S G Rane; G G Holz; K Dunlap
Journal:  Pflugers Arch       Date:  1987-08       Impact factor: 3.657

Review 7.  Structure and function of voltage-sensitive ion channels.

Authors:  W A Catterall
Journal:  Science       Date:  1988-10-07       Impact factor: 47.728

8.  Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel.

Authors:  A Mikami; K Imoto; T Tanabe; T Niidome; Y Mori; H Takeshima; S Narumiya; S Numa
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

9.  Voltage-activated calcium channels that must be phosphorylated to respond to membrane depolarization.

Authors:  D Armstrong; R Eckert
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

10.  Nonmodal gating of cardiac calcium channels as revealed by dihydropyridines.

Authors:  A E Lacerda; A M Brown
Journal:  J Gen Physiol       Date:  1989-06       Impact factor: 4.086

View more
  119 in total

Review 1.  Impact of recent molecular studies on evaluation of ventricular arrhythmias.

Authors:  D M Roden
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

2.  G(i)-dependent localization of beta(2)-adrenergic receptor signaling to L-type Ca(2+) channels.

Authors:  Y Chen-Izu; R P Xiao; L T Izu; H Cheng; M Kuschel; H Spurgeon; E G Lakatta
Journal:  Biophys J       Date:  2000-11       Impact factor: 4.033

3.  Novel functional properties of Ca(2+) channel beta subunits revealed by their expression in adult rat heart cells.

Authors:  Henry M Colecraft; Badr Alseikhan; Shoji X Takahashi; Dipayan Chaudhuri; Scott Mittman; Vasan Yegnasubramanian; Rebecca S Alvania; David C Johns; Eduardo Marbán; David T Yue
Journal:  J Physiol       Date:  2002-06-01       Impact factor: 5.182

4.  Modulation of the conductance of unitary cardiac L-type Ca(2+) channels by conditioning voltage and divalent ions.

Authors:  Ira R Josephson; Antonio Guia; Edward G Lakatta; Michael D Stern
Journal:  Biophys J       Date:  2002-11       Impact factor: 4.033

5.  Physiologic gating properties of unitary cardiac L-type Ca2+ channels.

Authors:  Ira R Josephson; Antonio Guia; Eric A Sobie; W Jonathan Lederer; Edward G Lakatta; Michael D Stern
Journal:  Biochem Biophys Res Commun       Date:  2010-05-10       Impact factor: 3.575

6.  Increased phosphorylation of the neuronal L-type Ca(2+) channel Ca(v)1.2 during aging.

Authors:  Monika A Davare; Johannes W Hell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-09       Impact factor: 11.205

7.  The Timothy syndrome mutation of cardiac CaV1.2 (L-type) channels: multiple altered gating mechanisms and pharmacological restoration of inactivation.

Authors:  Viktor Yarotskyy; Guofeng Gao; Blaise Z Peterson; Keith S Elmslie
Journal:  J Physiol       Date:  2008-12-15       Impact factor: 5.182

8.  Age-associated changes in beta-adrenergic modulation on rat cardiac excitation-contraction coupling.

Authors:  R P Xiao; H A Spurgeon; F O'Connor; E G Lakatta
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

Review 9.  New therapeutic targets in cardiology: arrhythmias and Ca2+/calmodulin-dependent kinase II (CaMKII).

Authors:  Adam G Rokita; Mark E Anderson
Journal:  Circulation       Date:  2012-10-23       Impact factor: 29.690

10.  Regulation of the calcium slow channel by cyclic GMP dependent protein kinase in chick heart cells.

Authors:  G E Haddad; N Sperelakis; G Bkaily
Journal:  Mol Cell Biochem       Date:  1995-07-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.